Location History:
- Beerse, BE (2014 - 2018)
- Essen, BE (2012 - 2022)
Company Filing History:
Years Active: 2012-2022
Title: **Frans Alfons Maria Van den Keybus: Innovator in Pharmaceutical Compounds**
Introduction
Frans Alfons Maria Van den Keybus is a notable inventor based in Essen, Belgium. With an impressive portfolio of 12 patents, he has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for the treatment of various disorders.
Latest Patents
Among his latest innovations are several patents related to [1,2,4]triazolo[1,5-a]pyrimidine compounds functioning as phosphodiesterase 2 (PDE2) inhibitors. These inventions involve unique derivatives that hold promise for treating neurological and psychiatric disorders. The inventions elaborate on pharmaceutical compositions involving these compounds and their processes of preparation, highlighting their potential in medical applications.
Career Highlights
Frans is currently associated with Janssen Pharmaceutica NV, a subsidiary of Johnson & Johnson, known for its commitment to innovation in the pharmaceutical industry. His work has significantly impacted how PDE2 inhibitors can be utilized in therapeutic contexts, underscoring his expertise in medicinal chemistry and drug development.
Collaborations
Throughout his career, Frans has collaborated with several noteworthy colleagues, including Yves Emiel Maria Van Roosbroeck and Gregor James MacDonald. These collaborations often lead to groundbreaking discoveries and advancements in pharmaceutical research, showcasing the power of teamwork in innovation.
Conclusion
Frans Alfons Maria Van den Keybus stands out as an influential inventor in the realm of pharmaceuticals. His recent patents reveal his dedication to addressing complex health issues through innovative compounds, ensuring that his contributions will continue to shape the future of medicine.